Treatment Verification Rates for Chlamydia and Gonorrhea by tracy12

VIEWS: 12 PAGES: 8

									Treatment Verification Rates for
  Chlamydia and Gonorrhea
      Region II IPP Advisory Meeting
               May 31, 2006

              Kelly Opdyke, MPH
            Cicatelli Associates Inc.
              Region II IPP
        Strategic Plan 2005-2009
 PRIORITY  3: Improve Appropriate and
 Timely Treatment for Persons Diagnosed
 with Chlamydial Infection and their
 Partners
     GOAL: 100% of Clients will be treated within
      30 days of diagnosis.
       • OBJECTIVE 3B: Increase by 10% annually the
         number of positive clients being treated within 30
         days of specimen collection.
CDC Performance Measures 2006
Measure 1 (IPP-CS1)
Among clients of IPP family planning clinics, the
 proportion of women with positive CT tests that
 are treated within 14 and 30 days of the date of
 specimen collection.

Measure 2 (IPP-CS1)
Among clients of IPP family planning clinics, the
 proportion of women with positive GC tests that
 are treated within 14 and 30 days of the date of
 specimen collection.
Treated for Chlamydia within 14 days
             (IPP-CS1)
                                  Region II IPP 2004-2005

                                 2004 (Jan-Jun)    2005 (Jan-Jun)

                   100%

                                                    74%76%
 Percent Treated




                   80%

                                             58%                    55%
                   60%
                                       41%
                   40%
                          28%
                                                                          21%
                                17%
                   20%

                    0%

                           NJ            NYC         NYS             PR

                                 Note: No data available for USVI
Treated for Chlamydia within 30 days
             (IPP-CS1)
                                  Region II IPP 2004-2005

                                 2004 (Jan-Jun)    2005 (Jan-Jun)

                   100%
                                                    83%86%
                                             79%
 Percent Treated




                   80%                 74%
                          66%
                   60%                                              55%
                                49%
                                                                          38%
                   40%

                   20%

                    0%

                           NJ            NYC         NYS             PR

                                 Note: No data available for USVI
Treated for Gonorrhea within 14 days
             (IPP-CS2)
                                  Region II IPP 2004-2005

                                 2004 (Jan-Jun)    2005 (Jan-Jun)
                                                                100%
                   100%
 Percent Treated




                   80%                              74%74%

                   60%                       51%
                                       39%
                   40%    30%

                   20%          16%


                    0%

                           NJ            NYC         NYS            PR

                                 Note: No data available for USVI
Treated for Gonorrhea within 30 days
             (IPP-CS2)
                                  Region II IPP 2004-2005

                                 2004 (Jan-Jun)    2005 (Jan-Jun)
                                                                100%
                   100%
                                                          86%
                                                    81%
 Percent Treated




                   80%
                                       69%
                          63%                61%
                   60%
                                45%
                   40%

                   20%

                    0%

                           NJ            NYC         NYS            PR

                                 Note: No data available for USVI
      Questions/Considerations
1)   What data sources are available to Projects to
     monitor timely treatment?

2)   What are the limitations of the data?

3)   What are the opportunities for/obstacles to
     providing timely treatment?

								
To top